ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,874Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 36

$918K Total Retail Price of All Prescriptions

Rank: 5 out of 36

675 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 675 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

5% of this provider’s 675 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 9,753 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
ATORVASTATIN CALCIUM 467 428 1 13
LEVOTHYROXINE SODIUM 340 303 2 3
OMEPRAZOLE 298 265 3 6
AMLODIPINE BESYLATE 296 283 4 2
SIMVASTATIN 242 223 5 1
LISINOPRIL 237 210 6 7
METOPROLOL TARTRATE 233 191 7 8
QUINAPRIL HCL 211 198 8 123
HYDROCHLOROTHIAZIDE 209 195 9 14
FUROSEMIDE 207 188 10 4
CARVEDILOL 193 189 11 21
GLIMEPIRIDE 193 173 11 53
METOPROLOL SUCCINATE 176 165 13 11
LIPITOR 145 141 14 78
RAMIPRIL 137 133 15 58
DIOVAN 132 129 16 36
AMLODIPINE BESYLATE-BENAZEPRIL 126 118 17 113
MELOXICAM 126 112 17 63
WARFARIN SODIUM 123 99 19 5
ALLOPURINOL 116 104 20 59
METFORMIN HCL 115 88 21 9
CLOPIDOGREL 113 93 22 30
DONEPEZIL HCL 110 110 23 10
SERTRALINE HCL 110 92 23 15
ESCITALOPRAM OXALATE 105 104 25 22
NAMENDA 104 104 26 12
NEXIUM 104 99 26 35
FAMOTIDINE 102 100 28 17
PANTOPRAZOLE SODIUM 101 87 29 32
CRESTOR 99 95 30 50
FENOFIBRATE 89 56 31 126
TRAZODONE HCL 83 68 32 54
METFORMIN HCL ER 82 71 33 162
TRAMADOL HCL 77 69 34 39
RISPERIDONE 76 75 35 28
MEGESTROL ACETATE 76 73 R 35 144
PLAVIX 75 65 37 42
ADVAIR DISKUS 75 71 37 45
GABAPENTIN 72 68 39 20
LYRICA 70 68 40 88
TAMSULOSIN HCL 69 68 41 23
ALBUTEROL SULFATE 67 67 42 40
LOSARTAN POTASSIUM 64 50 43 26
BENAZEPRIL HCL 64 64 43 157
SPIRIVA 63 61 45 73
OXYCONTIN 63 51 S2 45 104
FENTANYL 63 52 S2 45 43
OXYCODONE-ACETAMINOPHEN 61 57 S2 48 29
DIOVAN HCT 59 57 49 118
MECLIZINE HCL 58 49 50 124
PREDNISONE 58 56 50 55
ZOLPIDEM TARTRATE 58 44 50 25
JANUVIA 56 54 53 47
POTASSIUM CHLORIDE 56 53 53 19
CIPROFLOXACIN HCL 55 54 55 64
LANTUS SOLOSTAR 53 45 56 101
AZITHROMYCIN 53 46 56 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.